Trademark: 87843152
Word
ELZONRIS
Status Date
Tuesday, June 18, 2019
Registration Number
5782895
Registration Date
Tuesday, June 18, 2019
Filing Date
Wednesday, March 21, 2018
Published for Opposition
Tuesday, February 12, 2019
5 pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases
The wording "ELZONRIS" has no meaning in a foreign language.
Mar 28, 2018
New Application Office Supplied Data Entered
Dec 13, 2018
Approved For Pub - Principal Register
Jan 7, 2019
Assigned To Lie
Mar 24, 2018
New Application Entered
Jul 3, 2018
Assigned To Examiner
Jul 3, 2018
Non-Final Action Written
Jul 3, 2018
Non-Final Action E-Mailed
Jul 3, 2018
Notification Of Non-Final Action E-Mailed
Dec 12, 2018
Teas Response To Office Action Received
Dec 12, 2018
Correspondence Received In Law Office
Dec 12, 2018
Teas/Email Correspondence Entered
Feb 18, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 9, 2019
Law Office Publication Review Completed
Jan 23, 2019
Notification Of Notice Of Publication E-Mailed
Feb 12, 2019
Published For Opposition
Feb 12, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 18, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 9, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 10, 2019
Teas Statement Of Use Received
Apr 10, 2019
Use Amendment Filed
Apr 23, 2019
Case Assigned To Intent To Use Paralegal
Apr 23, 2019
Statement Of Use Processing Complete
May 16, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 18, 2019
Registered-Principal Register
Jun 18, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 15, 2019
Allowed Principal Register - Sou Accepted
Trademark Alertz updated from USPTO on 2030-01-24
